Resources

3 Resources for

remodulin

Subscribe to this listing via:
RSS
Email

BNET Resources

WallStreetGrapevine.com "Spotlight" Alert -NWAU, ACDO, BEAS.: M2 PRESSWIRE-11 November 2004-WallStreetGrapevine: WallStreetGrapevine.com "Spotlight" Alert -NWAU, ACDO, BEASC1994-2004 M2 COMMUNICATIONS LTD RDATE:11112004 WallStreetGrapevine.com "Heard on the Street" Alert - NWAU, ACDO, BEAS NowAuto, Inc. (OTC: NWAU) announced that wholly owned subsidiary Navicom, the leader in...; Tags: adjustment, B2B, BEA Systems Inc., Cadillac, car, Company, E-business/E-commerce, ebXML, INTERNET, Medicare, patient, Remodulin, SOFTWARE, U.S. Department of Defense; Research articles 2004-11-11
United Therapeutics Corp. Q2 2009 Earnings Call Transcript: Question-and-Answer Session Operator Instructions Operator Instructions Our first question comes from Salveen Kochnover – Collins Stewart Llc. Salveen Kochnover – Collins Stewart Llc Could you provide us with any color on Tyvaso pricing and just comment on the sales force positioning of Adcirca and Tyvaso to physicians. ...; Tags: Revenue, Patient, Call Transcript, Earnings, Pricing Strategy, Therapy, United Therapeutics Corp., Tyvaso, Remodulin, Seeking Alpha; Earnings calls 2009-07-31
United Therapeutics' 10-Q Suggests Dangerous Over-Reliance on Its Top Product: United Therapeutics Corp. derives almost all of its commercial sales from its top product Remodulin, a treatment for pulmonary arterial hypertension. In 2009, however, the biotechnology company could be drifting into troubled waters. For the six-months ended June 30, Remodulin accounted for approximately 95 percent of the $130.6 million in...; Tags: FDA, Patient, Therapy, Remodulin, Federal Government, Government, David Phillips; Blog posts 2008-08-27

Additional Resources

Accredo Health, Inc. Comments on CMS Remodulin Reimbursement Change and Increases Fiscal 2005 Earnings per Share Estimate: MEMPHIS, Tenn. -- Accredo Health, Incorporated (NASDAQ:ACDO) today reported that the Centers for Medicare and Medicaid Services CMS instructed the Durable Medical Equipment Regional Carriers DMERCs to adjust the 2004 pricing allowance for RemodulinR Treprostinil to $61.75 per milligram. The adjustment is retroactive to January 1, 2004, and allows Medicare...; Tags: Accredo Health Inc.; Research articles 2004-11-02
United Therapeutics Corp. Q4 2007 Earnings Call Transcript: Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Geoffrey Meacham. Geoffrey Meacham Hi, guys, thanks for taking my question. Martine Rothblatt Sure. Geoffrey Meacham I have a question for you on Remodulin, just a couple of questions on the quarter. First, can you talk a...; Tags: United Therapeutics Corp.; Earnings calls 2008-02-19

Silver Spring-based United Therapeutics Corp. gets Japanese: United Therapeutics Corp., of Silver Spring, a developer of pharmaceuticals to combat chronic and life-threatening cardiovascular, infectious and cancer diseases, said it signed an agreement with Mochida Pharmaceutical Co. Ltd., for the exclusive distribution in Japan of United Therapeutics' Remodulin, a drug used to treat pulmonary arterial hypertension, a dangerous...; Research articles 2007-03-28